ESC-HFA 2023: Late-Breaking Science Video Collection
Published: 23 May 2023
5m 48sPart 1 | Session 2 The PARAGLIDE-HF Trial
13m 32sPart 1 | Session 3 HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi
2m 45sPart 2 | Session 1 MONITOR-HF: Improving QoL& Reducing HF Hospitalisations with PAP Monitoring
3m 11sPart 2 | Session 3 APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis
4m 45sPart 2 | Session 4 DAPA-HF and DELIVER: KCCQ in Patients with Varying Ejection Fraction
8m 47sPart 2 | Session 5 DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF
4m 53sPart 2 | Session 6 NUDGE-FLU: Increasing Influenza Vaccination in HF Patients
3m 56sPart 2 | Session 7 DAPA-RESIST: Dapagliflozin Vs Metolazone in Diuretic-Resistant HF
5m 11sPart 2 | Session 8 TRANSFORM-HF: Torsemide Vs Furosemide on Quality of Life in Heart Failure
8m 22sPart 2 | Session 9 Diagnosis in Heart Failure in Women
3m 50sPart 2 | Session 10 Dapagliflozin and Peripheral Arterial Disease in Heart Failure
Get the most out of the new data from, Late-breaker host, Dr Harriette Van Spall and Dr James Januzzi wrap up of the most impactful trials and studies presented at Heart Failure 2023.
Delve into in-depth and critical discussions with Dr Van Spall in our thought-provoking Late-breaker Discussion series.
For concise and practical take-home messages for practice and cardiovascular research watch our 5-minute Expert Interviews conducted with investigators.
Watch our Behind the Heart Series to hear more from the personal perspectives of the investigators behind the top trials of HFA 2023.
More from this programme
Late-breaker Discussions with Dr Van Spall
About the episode
In this discussion, late-breaker host and principal investigator of PACT-HF, Dr Harriette Van Spall is joined by investigators Dr Jozine ter Maaten and Dr Tariq Ahmad. The focus of their conversation revolved around the latest data on the hospital-to-home transition in heart failure, drawing from the late-breaking data presented at HFA 2023 from three studies: PACT-HF, PROMPT-AHF and STRONG-HF Kidney.
Together, Dr Van Spall, Dr ter Maaten and Dr Ahmad provide a comprehensive review of the implications and insights derived from these three studies.
Harriette Van Spall
Associate Professor of Medicine, Director of E-Health and Virtual Care
Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.
She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.
Dr Van Spall is an Editorial Board…
Chief of Heart Failure
Dr Tariq Ahmad is Chief of Heart Failure at Yale University School of Medicine.
Dr Ahmad is a cardiologist who specialises in treating patients with end-stage heart failure and heart transplants. He also cares for patients with cardiomyopathies, which are diseases of the heart muscle, and advanced valvular diseases.
Jozine ter Maaten
Dr Jozine ter Maaten is a cardiologist at the University Medical Center Groningen, specializing in acute heart failure. Her research focuses on understanding congestion and improving diuretic response and outcomes in patients with this condition. Dr ter Maaten completed her PhD on 'Diuretic response and renal biomarkers in heart failure' in 2016 and has since been actively involved in research. She received a Mandema grant, enabling her to conduct a successful prospective study on renal blood flow in acute heart failure patients during her postdoc in Genk, Belgium.